Amarin Corp Plc (AMRN)

[Number sleven]

Kiwi, l don't think any more studies are required. The scientific committee understands the value of icosapent ethyl. This is not my opinion. I make this statement based on medical treatment guidelines. France and Italy have both backed Vazkepa. They just don't want to pay for it. I do a fair amount of reading. To me this looks like an economic issue, not a scientific/medical debate. Eventually the math should resolve this in our favor. The cost of prevention is less than the cost of post event treatment. Germany never had any intentions of reimbursement. I base this on the comparator drug. They will avoid the expense as long as they can. Eventually they will be forced to pay up. The adoption of new medical therapy is a top down process.
Sleven,